Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 67-74 , January 2008

Feasibility studies of 4′-[methyl-11C]thiothymidine as a tumor proliferation imaging agent in mice

Received 4 July 2007 ,Revised 5 September 2007 ,Accepted 2 October 2007.

References 

  1. Alauddin MM, Conti PS, Fissekis JD. Synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU). J Label Compd Radiopharm. 2002;45:583–590
  2. Conti PS, Alauddin MM, Fissekis JR, Schmall B, Watanabe KA. Synthesis of 2′-fluoro-5-[11C]-methyl-1-β-d-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for the in vivo study of cellular proliferation with PET. Nucl Med Biol. 1995;22:783–789
  3. Mangner TJ, Klecker RW, Anderson L, Shields AF. Synthesis of 2′-deoxy-2′-[18F]fluoro-β-d-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol. 2003;30:215–224
  4. Sun H, Solan A, Mangner TJ, Vaishampayan U, Muzik O, Collins JM, et al. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer. Eur J Nucl Med Mol Imaging. 2005;32:15–22
  5. Shields AF, Grierson JR, Dohmen BM, Machulla H-J, Stayanoff JC, Lawhorn-crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334–1336
  6. Grierson JR, Shields AF. Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol. 2000;27:143–156
  7. Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA. Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol. 2004;31:829–837
  8. Toyohara J, Fujibayashi Y. Trends in nucleoside tracers for PET imaging of cell proliferation. Nucl Med Biol. 2003;30:681–685
  9. Shields AF. PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. J Nucl Med. 2003;44:1432–1434
  10. Krohn KA, Mankoff DA, Muzi M, Link JM, Spence AM. True tracers: comparing FDG with glucose and FLT with thymidine. Nucl Med Biol. 2005;32:663–671
  11. Johansson NG, Eriksson S. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochim Pol. 1996;43:143–160
  12. Toyohara J, Waki A, Takamatsu S, Yonekura Y, Magata Y, Fujibayashi Y. Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. Nucl Med Biol. 2002;29:281–287
  13. Kawai H, Toyohara J, Kado H, Nakagawa T, Takamatsu S, Furukawa T, et al. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring. Nucl Med Biol. 2006;33:29–35
  14. Koole LH, Plavec J, Liu H, Vincent BR, Dyson MR, Coe PL, et al. Conformation of two 4′-thio-2′-deoxynucleoside analogs studied by 500-MHz 1H NMR spectroscopy and X-ray crystallography. J Am Chem Soc. 1992;114:9936–9943
  15. Parker WB, Shaddix SC, Rose LM, Tiwari KN, Montgomery JA, Secrist JA, et al. Metabolism and metabolic actions of 4′-thiothymidine in L1210 cells. Biochem Pharmacol. 1995;50:687–695
  16. Toyohara J, Kumata K, Fukushi K, Irie T, Suzuki K. Evaluation of 4′-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging. J Nucl Med. 2006;47:1717–1722
  17. Toyohara J, Okada M, Toramatsu C, Fukumura T, Takahashi K, Fukushi K, et al. Radiosynthesis of 4′-[methyl-11C]thiothymidine for imaging DNA synthesis in vivo. J Labelled Compd Radiopharm. 2007;50:S57
  18. Toyohara J, Hayashi A, Sato M, Tanaka H, Haraguchi K, Yoshimura Y, et al. Rationale of 5-125I-4′-thio-2′-deoxyuridine as a potential iodinated proliferation marker. J Nucl Med. 2002;43:1218–1226
  19. Suzuki K, Inoue O, Hashimoto K, Yamasaki T, Kuchiki M, Tamate K. Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors. Int J Appl Radiat Isot. 1985;36:971–976
  20. Kassis AI, Foulon CF, Adelstein SJ. Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides from stannyl precursors. United States Patent 5720935, 1998.
  21. Samuelsson L, Långström B. Synthesis of 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-[methyl-11C]thymine ([11C]FMAU) via a Stille cross-coupling reaction with [11C]methyl iodide. J Label Compd Radiopharm. 2003;46:263–272
  22. Quackenbush RC, Shields AF. Local re-utilization of thymidine in normal mouse tissues as measured with iododeoxyuridine. Cell Tissue Kinet. 1988;21:381–387
  23. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601–609
  24. Wuest F, Berdt M, Kniess T. Carbon-11 labeling chemistry based upon [11C]methyl iodide. In:  Schubiger PA,  Lehman L,  Fribe M editor. PET chemistry. The driving force in molecular imaging. Berlin: Springer-Verlag; 2007;p. 183–213
  25. Suzuki M, Doi H, Björkman M, Långström B, Watanabe Y, Noyori R. Rapid coupling of methyl iodide with aryltributylstannanes mediated by palladium(0) complexes: a general protocol for the synthesis of 11CH3-labeled PET tracers. Chem Eur J. 1997;3:2039–2042
  26. Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson LM, et al. Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: validation in patients with lung cancer. J Nucl Med. 2005;46:272–284
  27. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7
  28. van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695–700
  29. Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, et al. Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004;31:407–418
  30. Sun H, Mangner TJ, Collins JM, Muzik O, Douglas K, Shields AF. Imaging DNA synthesis in vivo with 18F-FMAU and PET. J Nucl Med. 2005;46:292–296
  31. Nimmagadda S, Manger TJ, Sun H, Klecker RW, Muzik O, Lawhorn-Crews JM, et al. Biodistribution and radiation dosimetry estimates of 1-(2′-deoxy-2′-18F-fluoro-1-β-d-arabinofuranosyl)-5-bromouracil: PET imaging studies in dogs. J Nucl Med. 2005;46:1916–1922

☆ This work was supported by a Grant-in-Aid for Molecular Imaging Program (Research Base for positron emission tomography Diagnosis) from the Ministry of Education, Science and Culture, Tokyo, Japan.

PII: S0969-8051(07)00249-1

doi: 10.1016/j.nucmedbio.2007.10.001

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 67-74 , January 2008

Article Tools

* Image Usage & Resolution